Although lymphopenia preferentially affects CD8+ T cells [460,461], both CD4+ and CD8+ T cell levels were reduced in number and frequency but exhibited increased activation in COVID-19 patients [69,461,462]. This evidence concerns the gene CD8A and COVID-19.